Prognostic Impact of Immunohistochemical p53 Expression in Bone Marrow Biopsy in Higher Risk MDS: a Pilot Study

BACKGROUND AND OBJECTIVES: Mutations of the TP53 gene have an unfavorable prognosis in Myelodysplastic Syndromes (MDS). The product of the TP53 gene is the p53 protein. Most of the TP53 mutations entail the accumulation of the protein in the nucleus of tumor cells. The immunohistochemical (IHC) stai...

Descripción completa

Detalles Bibliográficos
Autores principales: Molteni, Alfredo, Ravano, Emanuele, Riva, Marta, Nichelatti, Michele, Bandiera, Laura, Crucitti, Lara, Truini, Mauro, Cairoli, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402551/
https://www.ncbi.nlm.nih.gov/pubmed/30858953
http://dx.doi.org/10.4084/MJHID.2019.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402551/
https://www.ncbi.nlm.nih.gov/pubmed/30858953
http://dx.doi.org/10.4084/MJHID.2019.015

Ejemplares similares